» Articles » PMID: 23503464

Regulation of Several Androgen-induced Genes Through the Repression of the MiR-99a/let-7c/miR-125b-2 MiRNA Cluster in Prostate Cancer Cells

Overview
Journal Oncogene
Date 2013 Mar 19
PMID 23503464
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The androgen receptor (AR) stimulates and represses gene expression to promote the initiation and progression of prostate cancer. Here, we report that androgen represses the miR-99a/let7c/125b-2 cluster through AR and anti-androgen drugs block the androgen-repression of the miRNA cluster. AR directly binds to the host gene of the miR-99a/let7c/125b-2 cluster, LINC00478. Expression of the cluster is repressed or activated by chromatin remodelers EZH2 or JMJD3 in the presence or absence of androgen, respectively. Bioinformatics analysis reveals a significant enrichment of targets of miR-99a, let-7c and miR-125b in androgen-induced gene sets, suggesting that downregulation of the miR-99a/let7c/125b-2 cluster by androgen protects many of their target mRNAs from degradation and indirectly assists in the gene induction. We validated the hypothesis with 12 potential targets of the miR-99a/let7c/125b-2 cluster induced by androgen: 9 out of the 12 mRNAs are downregulated by the microRNA cluster. To ascertain the biological significance of this hypothesis, we focused on IGF1R, a known prostate cancer growth factor that is induced by androgen and directly targeted by the miR-99a/let7c/125b-2 cluster. The androgen-induced cell proliferation is ameliorated to a similar extent as anti-androgen drugs by preventing the repression of the microRNAs or induction of IGF1R in androgen-dependent prostate cancer cells. Expression of a microRNA-resistant form of IGF1R protects these cells from inhibition by the miR-99a/let7c/125b-2 cluster. These results indicate that a thorough understanding of how androgen stimulates prostate cancer growth requires not only an understanding of genes directly induced/repressed by AR, but also of genes indirectly induced by AR through the repression of key microRNAs.

Citing Articles

MiR-99a-5p up-regulates LDLR and functionally enhances LDL-C uptake via suppressing PCSK9 expression in human hepatocytes.

Chen X, Liu Y, Zhou Q, Zhang C, Wang W, Xu M Front Genet. 2024; 15:1469094.

PMID: 39628814 PMC: 11611869. DOI: 10.3389/fgene.2024.1469094.


miR-4448/Girdin/Akt/AMPK axis inhibits EZH2-mediated EMT and tumorigenesis in small-cell lung cancer.

Koyama N, Ishikawa Y, Ohta H, Aoki T, Kyoyama H, Aoshiba K Cancer Med. 2024; 13(19):e70093.

PMID: 39400978 PMC: 11476246. DOI: 10.1002/cam4.70093.


An ALS-associated mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner.

Christoforidou E, Moody L, Joilin G, Simoes F, Gordon D, Talbot K Dis Model Mech. 2024; 17(5).

PMID: 38721655 PMC: 11152562. DOI: 10.1242/dmm.050638.


Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.

Hochberg J, Sohal A, Handa P, Maliken B, Kim T, Wang K JHEP Rep. 2023; 5(6):100729.

PMID: 37179785 PMC: 10172698. DOI: 10.1016/j.jhepr.2023.100729.


Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer.

Lin Y, Tan H, Yu G, Zhan M, Xu B Int J Mol Sci. 2023; 24(2).

PMID: 36674820 PMC: 9860629. DOI: 10.3390/ijms24021305.


References
1.
Agger K, Cloos P, Christensen J, Pasini D, Rose S, Rappsilber J . UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature. 2007; 449(7163):731-4. DOI: 10.1038/nature06145. View

2.
Takayama K, Kaneshiro K, Tsutsumi S, Horie-Inoue K, Ikeda K, Urano T . Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene. 2007; 26(30):4453-63. DOI: 10.1038/sj.onc.1210229. View

3.
Pandini G, Mineo R, Frasca F, Roberts Jr C, Marcelli M, Vigneri R . Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res. 2005; 65(5):1849-57. DOI: 10.1158/0008-5472.CAN-04-1837. View

4.
Zheng C, Yinghao S, Li J . MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Med Oncol. 2011; 29(2):815-22. DOI: 10.1007/s12032-011-9934-8. View

5.
Ozkan E . Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review. Mol Cell Endocrinol. 2011; 344(1-2):1-24. DOI: 10.1016/j.mce.2011.07.002. View